Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03417505 · ClinicalTrials.gov registry record · NA
Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye
A NA study, sponsored by Tangible Science.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03417505 is a NA study that has completed, run by Tangible Science. The registered enrollment target is 21 participants.
The verdict
NCT03417505, a NA study, has completed, sponsored by Tangible Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Tangible Hydra-PEG is a novel coating technology designed to improve lens wettability, deposit resistance, and tear film breakup time. This is a randomized double masked cross-over study to examine contact lens discomfort and dry eye symptoms with Tangible Hydra-PEG treated scleral lens wear compared to untreated scleral lens wear in the dry eye patient population.
Interventions
- DEVICE Scleral lenses treated with Tangible Hydra-PEG
- DEVICE Untreated scleral lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-01-30 |
| Est. Completion | 2019-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03417505
The ClinicalTrials.gov registry entry for NCT03417505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tangible Science, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Scleral lenses treated with Tangible Hydra-PEG is the first listed.
NCT03417505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03417505 about?
NCT03417505 is a clinical study titled "Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye". Tangible Hydra-PEG is a novel coating technology designed to improve lens wettability, deposit resistance, and tear film breakup time. This is a randomized double masked cross-over study to examine contact lens discomfort and dry eye symptoms with Tangible Hydra-PEG treated scleral lens wear compare...
What is the current status of trial NCT03417505?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-01-30. Estimated completion is 2019-01-04.
What interventions are being tested in trial NCT03417505?
The interventions under investigation include: Scleral lenses treated with Tangible Hydra-PEG (DEVICE), Untreated scleral lenses (DEVICE).
Who is sponsoring clinical trial NCT03417505?
This trial is sponsored by Tangible Science, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.